PHBI – Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company CARSON CITY, NV, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an  affirmed  memorandum  of  understanding  (MOU)  to  acquire  Long  Valley Farms LLC,...

PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market CARSON CITY, NV, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp and Cannabis...

PHBI – Pharmagreen Previews Imminent Next Strategic Steps Advancing Its Proprietary Cannabis Tissue Culture Technology Into Recurring Revenue Generation CARSON CITY, NV, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today continued in the release of a series of management updates from CEO Peter Wojcik as the company...

PHBI – Pharmagreen Plans To Transition Cannabis Industry Economics Making Adoption Of Its Proprietary Plant Tissue Technology An Industry Standard CARSON CITY, NV, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today released a second management update form CEO Peter Wojcik.  Today’s update provides further...

PHBI - Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset Carson City, Nevada, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update is the first in a series of...